Status:
COMPLETED
Investigation of Cardiopulmonary Parameters, Motor Development and Muscle Strength in DS With and Without CHD
Lead Sponsor:
Atılım University
Conditions:
Congenital Heart Defects
Down Syndrome
Eligibility:
All Genders
6-5 years
Brief Summary
Congenital heart diseases (CHD) are detected in 40-60% of individuals with Down syndrome (DS) and increase the risk of developmental delay in the presence of syndromes. The aim of the study was to com...
Eligibility Criteria
Inclusion
- Diagnosed with Down syndrome as a result of genetic analysis,
- For the congenital heart disease group; undergoing cardiac surgery at least 6 months before the evaluation, diagnosed as CHD by a pediatric cardiologist based on echocardiographic findings,
- For the group without congenital heart disease, patients who have not undergone cardiac surgery, are asymptomatic with a septal defect smaller than 4-5 mm, are expected to close, and are hemodynamically normal by a pediatric cardiologist,
- Children whose families were informed about the study and gave written consent to participate in the study were included in the study.
Exclusion
- Having another genetic abnormality other than Down syndrome,
- undergoing surgery other than cardiac surgery,
- Having an orthopedic or neurological problem,
- Respiratory support,
- With atlantoaxial instability,
- Children with hematological disease were not included in the study.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT05191654
Start Date
October 1 2020
End Date
June 30 2021
Last Update
January 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Atılım University
Ankara, Turkey (Türkiye)